CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 5 enrolled
Drug / intervention
Ekso GT™ exoskeletondevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04000373
NCT04000373N/ACompleted
CompareCT.gov

Pilot Study of Powered Exoskeleton Use for Gait Rehabilitation in Individuals With Multiple Sclerosis

The Cleveland Clinic·interventional·Posted Jun 27, 2019·Updated Jun 27, 2022

In Brief

A clinical study evaluating Ekso GT™ exoskeleton for Multiple Sclerosis and Gait Disorders, Neurologic. Completed, enrolled 5 participants across 1 site.

Detailed Summary

The investigator plans to test the use of the Ekso Bionics® Gait Training (Ekso GT™) exoskeleton for gait training in MS patients. The device will solely be used in the clinic under direct supervision from a physical therapist. This is a small PI-initiated uncontrolled pilot study to gather safety and feasibility data on the exoskeleton in individuals with MS and walking impairment.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsMultiple Sclerosis, Gait Disorders, Neurologic
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
2020202120222023202420252026
First PostedJun 27, 2019
Enrollment StartJul 23, 2019
Primary CompletionJan 9, 2020
TodayJul 2, 2026
Enrollment to primary: 6 monthsPosted 7.0 years ago

Interventions

Ekso GT™ exoskeletondevice

The rehabilitation treatment will consist of 3 sessions per week for 8 weeks, for a total of 24 sessions. Missed sessions will be made up if possible. Each session will be scheduled for 60 minutes, and will consist of stretching, overground gait training, and gait training with the study device. Rest periods will be provided as necessary during the training visits.